Literature DB >> 29797626

Embryonal Tumor with Multilayered Rosettes, C19MC-Altered: Clinical, Pathological, and Neuroimaging Findings.

Bing Wang1, Bhanu Gogia1, Gregory N Fuller2, Leena M Ketonen1.   

Abstract

BACKGROUND AND
PURPOSE: Embryonal tumor with multilayered rosettes (ETMR), C19MC-altered, is a recently described, rare central nervous system tumor. To our knowledge, the imaging findings of this tumor have not been systematically evaluated in the neuroradiology literature. We present here the clinical, radiological, and pathological correlation of a case series of this very rare tumor, including the full range of anatomic compartment presentations (supratentorial, infratentorial, and spinal).
METHODS: We retrospectively analyzed 7 (4M, 3F) pathologically-proven cases of ETMR referred to our institution between 2007 and 2017. We demonstrate the imaging characteristics of this tumor on CT and MRI with advanced imaging.
RESULTS: All of the patients are children (ages 1-12). On MR imaging of ETMR, contrast enhancement is often heterogeneous and minimal if any, and there is no significant surrounding T2 fluid-attenuated inversion recovery (FLAIR) hyperintensity to suggest edema. The lesions were often expansile with no evidence of infiltration of the fiber tracks that were displaced by the tumor mass. Diffusion-weighted imaging often demonstrated restricted diffusion within ETMRs. On magnetic resonance spectroscopy (MRS), the choline/creatine (Cho/Cr) ratio is increased, with low N-acetylaspartate (NAA) or NAA/Cho ratio, typical of high-grade tumors.
CONCLUSION: We demonstrate the conventional and advanced imaging characteristics of ETMR, including MRS and diffusion tensor imaging, which, to our knowledge, have not been systematically evaluated in the radiology literature. The knowledge gained may potentially impact patient management, especially in inoperable cases and in locations where it is risky to perform a biopsy.
© 2018 by the American Society of Neuroimaging.

Entities:  

Keywords:  C19MC-altered; ETMR; Pediatric; embryonal; tumor

Mesh:

Substances:

Year:  2018        PMID: 29797626     DOI: 10.1111/jon.12524

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  5 in total

Review 1.  Embryonal tumor with multilayered rosettes: illustrative case and review of the literature.

Authors:  Sofiene Bouali; Alia Zehani; Maha Mahmoud; Imed Ben Said; Jalel Kallel; Hafedh Jemel
Journal:  Childs Nerv Syst       Date:  2018-09-14       Impact factor: 1.475

2.  CT and Multimodal MR Imaging Features of Embryonal Tumors with Multilayered Rosettes in Children.

Authors:  V Dangouloff-Ros; A Tauziède-Espariat; C-J Roux; R Levy; D Grévent; F Brunelle; A Gareton; S Puget; K Beccaria; T Blauwblomme; J Grill; C Dufour; P Varlet; N Boddaert
Journal:  AJNR Am J Neuroradiol       Date:  2019-03-07       Impact factor: 3.825

3.  Embryonal tumor with multilayered rosettes, C19MC-altered (ETMR): a newly defined pediatric brain tumor.

Authors:  Yu-Chun Pei; Guo-Hao Huang; Xiao-Hong Yao; Xiu-Wu Bian; Fei Li; Yan Xiang; Lin Yang; Sheng-Qing Lv; Jun Liu
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

Review 4.  ETMR: a tumor entity in its infancy.

Authors:  Sander Lambo; Katja von Hoff; Andrey Korshunov; Stefan M Pfister; Marcel Kool
Journal:  Acta Neuropathol       Date:  2020-06-29       Impact factor: 17.088

5.  A modified IRS-III chemotherapy regimen leads to prolonged survival in children with embryonal tumor with multilayer rosettes.

Authors:  Derek Hanson; Lindsey M Hoffman; Sumanth Nagabushan; Liliana C Goumnerova; Allison Rathmann; Timothy Vogel; David S Ziegler; Susan Chi
Journal:  Neurooncol Adv       Date:  2020-09-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.